Alginate rafts and their characterisation

被引:83
作者
Hampson, FC [1 ]
Farndale, A [1 ]
Strugala, V [1 ]
Sykes, J [1 ]
Jolliffe, IG [1 ]
Dettmar, PW [1 ]
机构
[1] Reckitt Benckiser Healthcare UK Ltd, Kingston Upon Hull HU8 7DS, N Humberside, England
关键词
alginate; gastro-oesophageal reflux; raft formulation;
D O I
10.1016/j.ijpharm.2005.01.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alginate/antacid anti-reflux preparations are designed to provide symptom relief by forming a physical barrier on top of the stomach contents in the form of a neutral floating gel or raft. This study tested the in vitro effectiveness of a range of liquid products in forming rafts that were cohesive, buoyant, Voluminous, resistant to reflux and durable under conditions of movement (resilient). The products tested had a wide range of acid neutralising capacities (ANCs). It was found that products with a high ANC and no calcium ion Source formed rafts of low strength, weight and volume, which appeared more as floating precipitates than coherent gels. Products with a high ANC and a calcium ion source formed medium strength, weight and volume rafts. Products with a low ANC formed strong coherent rafts with medium to large weight and volume, and those with low ANC and a calcium ion source formed the strongest rafts. Products with stronger rafts were found to be more resilient and more resistant to reflux in an in vitro reflux model. Significant overall differences in raft buoyancy were found between products forming coherent rafts but these could not be related to the product formulation or amount of available carbon dioxide. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 25 条
[1]  
Bryan JL, 2001, GASTROENTEROLOGY, V120, pA434
[3]   MECHANISMS OF GASTRO-ESOPHAGEAL REFLUX IN PATIENTS WITH REFLUX ESOPHAGITIS [J].
DODDS, WJ ;
DENT, J ;
HOGAN, WJ ;
HELM, JF ;
HAUSER, R ;
PATEL, GK ;
EGIDE, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) :1547-1552
[4]  
GOODALL JS, 1977, ACTA THERAP, V3, P141
[5]   URONIC ACID SEQUENCE IN ALGINATE FROM DIFFERENT SOURCES [J].
HAUG, A ;
LARSEN, B ;
SMIDSROD, O .
CARBOHYDRATE RESEARCH, 1974, 32 (02) :217-225
[6]  
Jolliffe IG, 2001, GUT, V48, pA26
[7]  
KNIGHT LC, 1988, NUCL MED BIOL, V15, P563
[8]  
LAMBERT JR, 1990, ALIMENT PHARM THERAP, V4, P615
[9]  
Lindow SW, 2003, INT J CLIN PRACT, V57, P175
[10]   Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivo [J].
Marciani, L ;
Little, SL ;
Snee, J ;
Coleman, NS ;
Tyler, DJ ;
Sykes, J ;
Jolliffe, IG ;
Dettmar, PW ;
Spiller, RC ;
Gowland, PA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (10) :1351-1356